Conservative treatment of stage III lung cancer using chemoradiotherapy in hypofractionation mode, case report

by N. V. Marinichenko, K. K. Laktionov, A. V. Nazarenko, T. N. Borisova, M. S. Ardzinba, A. A. Fedorova, P. V. Murashova, M. S. Ardzinba
Published 2020-07-01

Rational approach to the treatment of EGFR-positive lung cancer

by E. V. Reutova, K. K. Laktionov, D. I. Yudin, M. S. Ardzinba
Published 2019-12-01

TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT

by K. K. LAKTIONOV, E. V. REUTOVA, M. S. ARDZINBA, N. A. MESCHERYAKOVA
Published 2017-06-01

Prospects for the development of adjuvant therapy for non-small cell lung cancer

by K. K. Laktionov, A. M. Kazakov, E. V. Reutova, M. S. Ardzinba, A. L. Arzumanian
Published 2020-11-01

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

by E. S. Denisova, M. S. Ardzinba, K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, G. V. Shcherbakova, N. V. Marinichenko
Published 2020-07-01

Pseudoprogression in patients on immunotherapy

by D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Published 2019-06-01

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

by K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba
Published 2019-06-01

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION

by К. К. LAKTIONOV, М. V. PEREGUDOVA, V. V. BREDER, E. V. REUTOVA, D. A. PEREGUDOV, M. S. ARDZINBA, P. A. CHERNENKO, D. T. MARINOV
Published 2016-12-01

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

by K. K. Laktionov, V. V. Breder, D. I. Yudin, K. A. Sarantseva, L. V. Laktionova, M. S. Ardzinba, E. V. Reutova, A. V. Egorova
Published 2019-12-01

Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature

by N. V. Marinichenko, K. K. Laktionov, A. V. Nazarenko, V. V. Breder, T. N. Borisova, D. I. Yudin, M. S. Ardzinba, A. V. Egorova, A. A. Fedorova
Published 2019-06-01

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

by K K Laktionov, E V Reutova, L A Nelyubina, M Yu Pitkevich, M A Okruzhnova, M S Ardzinba, D I Yudin, I A Demidova, A R Zaretsky
Published 2018-06-01

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer

by D. I. Yudin, K. K. Laktionov, D. T. Marinov, V. V. Breder, A. K. Allakhverdiev, T. N. Borisova, A. H. Bekyashev, K. P. Laktionov, V. A. Aleshin, M. S. Ardzinba
Published 2018-11-01